These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 36114171)

  • 1. Structural insights into the Omicron spike trimer: tackling the challenges of continuously evolving SARS-CoV-2 variants.
    Ou J; Wu J; Zhang Q
    Signal Transduct Target Ther; 2022 Sep; 7(1):322. PubMed ID: 36114171
    [No Abstract]   [Full Text] [Related]  

  • 2. Spike protein of SARS-CoV-2 variants: a brief review and practical implications.
    Candido KL; Eich CR; de Fariña LO; Kadowaki MK; da Conceição Silva JL; Maller A; Simão RCG
    Braz J Microbiol; 2022 Sep; 53(3):1133-1157. PubMed ID: 35397075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations and Evolution of the SARS-CoV-2 Spike Protein.
    Magazine N; Zhang T; Wu Y; McGee MC; Veggiani G; Huang W
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35337047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell epitopes are largely conserved in the SARS-CoV-2 Omicron subvariant (BA.1, BA.2, BA.3, and GKA).
    Li H; Chen Z; Liu X; Hu P
    J Med Virol; 2022 Oct; 94(10):4591-4592. PubMed ID: 35676232
    [No Abstract]   [Full Text] [Related]  

  • 5. Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections.
    Medits I; Springer DN; Graninger M; Camp JV; Höltl E; Aberle SW; Traugott MT; Hoepler W; Deutsch J; Lammel O; Borsodi C; Puchhammer-Stöckl E; Zoufaly A; Weseslindtner L; Aberle JH; Stiasny K
    Front Immunol; 2022; 13():946318. PubMed ID: 35928813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron.
    Maeda R; Fujita J; Konishi Y; Kazuma Y; Yamazaki H; Anzai I; Watanabe T; Yamaguchi K; Kasai K; Nagata K; Yamaoka Y; Miyakawa K; Ryo A; Shirakawa K; Sato K; Makino F; Matsuura Y; Inoue T; Imura A; Namba K; Takaori-Kondo A
    Commun Biol; 2022 Jul; 5(1):669. PubMed ID: 35794202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021.
    Blomquist PB; Bridgen J; Bray N; O'Connell AM; West D; Groves N; Gallagher E; Utsi L; Jarvis CI; Hardstaff JL; Byers C; Metelmann S; Simons D; Zaidi A; Twohig KA; Savagar B; Løchen A; Ryan C; Wrenn K; Saavedra-Campos M; Abedin Z; Florence I; Cleary P; Elson R; Vivancos R; Lake IR
    Euro Surveill; 2022 Mar; 27(11):. PubMed ID: 35301981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and biochemical mechanism for increased infectivity and immune evasion of Omicron BA.2 variant compared to BA.1 and their possible mouse origins.
    Xu Y; Wu C; Cao X; Gu C; Liu H; Jiang M; Wang X; Yuan Q; Wu K; Liu J; Wang D; He X; Wang X; Deng SJ; Xu HE; Yin W
    Cell Res; 2022 Jul; 32(7):609-620. PubMed ID: 35641567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
    Li Y; Wang X; Jin J; Ma Z; Liu Y; Zhang X; Su B
    J Med Virol; 2022 Aug; 94(8):3998-4004. PubMed ID: 35474581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants.
    Zhang J; Han ZB; Liang Y; Zhang XF; Jin YQ; Du LF; Shao S; Wang H; Hou JW; Xu K; Lei W; Lei ZH; Liu ZM; Zhang J; Hou YN; Liu N; Shen FJ; Wu JJ; Zheng X; Li XY; Li X; Huang WJ; Wu GZ; Su JG; Li QM
    Elife; 2022 Aug; 11():. PubMed ID: 36004719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 as a betacoronavirus comprises five structural proteins?
    Zandi M; Soltani S; Feyzi K
    Infect Genet Evol; 2021 Oct; 94():105011. PubMed ID: 34293483
    [No Abstract]   [Full Text] [Related]  

  • 14. A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge.
    Zhou B; Zhou R; Tang B; Chan JF; Luo M; Peng Q; Yuan S; Liu H; Mok BW; Chen B; Wang P; Poon VK; Chu H; Chan CC; Tsang JO; Chan CC; Au KK; Man HO; Lu L; To KK; Chen H; Yuen KY; Dang S; Chen Z
    Nat Commun; 2022 Jun; 13(1):3589. PubMed ID: 35739114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Spike Gene Target Failure to Estimate Growth Rate of the Alpha and Omicron Variants of SARS-CoV-2.
    Smith BF; Graven PF; Yang DY; Downs SM; Hansel DE; Fan G; Qin X
    J Clin Microbiol; 2022 Apr; 60(4):e0257321. PubMed ID: 35254096
    [No Abstract]   [Full Text] [Related]  

  • 16. Structural basis of severe acute respiratory syndrome coronavirus 2 infection.
    Ge J; Zhang S; Zhang L; Wang X
    Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and structural bases of potent broadly neutralizing antibodies from 3-dose vaccinees that are highly effective against diverse SARS-CoV-2 variants, including Omicron sublineages.
    Wang L; Fu W; Bao L; Jia Z; Zhang Y; Zhou Y; Wu W; Wu J; Zhang Q; Gao Y; Wang K; Wang Q; Qin C; Wang X
    Cell Res; 2022 Jul; 32(7):691-694. PubMed ID: 35672388
    [No Abstract]   [Full Text] [Related]  

  • 18. Convolutional Neural Networks Based on Sequential Spike Predict the High Human Adaptation of SARS-CoV-2 Omicron Variants.
    Nan BG; Zhang S; Li YC; Kang XP; Chen YH; Li L; Jiang T; Li J
    Viruses; 2022 May; 14(5):. PubMed ID: 35632811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.
    Li T; Zheng Q; Yu H; Wu D; Xue W; Xiong H; Huang X; Nie M; Yue M; Rong R; Zhang S; Zhang Y; Wu Y; Wang S; Zha Z; Chen T; Deng T; Wang Y; Zhang T; Chen Y; Yuan Q; Zhao Q; Zhang J; Gu Y; Li S; Xia N
    Emerg Microbes Infect; 2020 Dec; 9(1):2076-2090. PubMed ID: 32897177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.